$IBO Cashflow Statement | Understand Stock

$IBO

$3.87 -$0.12 (3.01%) Close

Financial Statements

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023
Cash flows from operating activities:
Net loss
Loss from continuing operations
Adjustments to reconcile loss from operations to net cash used by operating activities:
Depreciation and amortization
Stock based compensation
Issuance of shares for professional services rendered
Accrued interest on notes payable
Change in deferred tax liability
Change in fair value of note payable, related party
Impairment of inventory
Loss on disposal of fixed assets
Impairment of fixed assets
Impairment of goodwill
Decrease (increase) in assets:
Other receivable
Accounts receivable
Inventory
Prepaid expenses and other current assets
Increase (decrease) in liabilities:
Accounts payable
Accrued expenses
Net cash used operating activities
Cash flows from investing activities:
Purchase of property, plant and equipment
Note receivable investment, net
Payments received on notes receivable
Net cash provided by investing activities
Cash flows from financing activities:
Borrowings from revolving lines of credit, net
Borrowings from related party
Payments to related party
Borrowings of note payable, related party
Issuances of common stock, net of issuance costs
Net cash (used) provided by financing activities
Net increase (decrease) in cash
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year

Comments